The title of the lecture is: "Drug Discovery in Industry and Academia - from Conceptualization to new Mechanisms and new Modalities." Prof. Oliver Plettenburg will give an overview on drug discovery in industry and academia and will show examples how new ideas are translated to discovery of unique mechanisms of action and to development of novel drug modalities.
Admission to the lecture is open and no registration is required. The lecture will be held in English.
About Prof. Oliver Plettenburg
Oliver Plettenburg is Director of the Institute of Medicinal Chemistry at the Helmholtz Center for Environmental Health in Munich and Professor for Medicinal Chemistry at Leibniz Universität Hannover. Previously he held various positions within the pharmaceutical industry, last as Head of Biosensors & Chemical Probes in Sanofi’s Diabetes Division. The group’s main responsibility was to support evaluation of validity of novel targets, provide tools to visualize pathologically relevant processes, to develop new methods to quantify important biomarkers and to explore new treatment options at the drug-device interface.
Oliver was with Sanofi for 14 years. Before joining the Diabetes Division he worked as a project leader in several medicinal chemistry projects in the area of Diabetes and Cardiovascular Diseases and was deeply involved in the Chemical Biology approach within Aventis.
After receiving his PhD in organic chemistry, Oliver Plettenburg joined The Scripps Research Institute as a postdoctoral fellow, working in the group of Chi-Huey Wong on the total synthesis of glycosyl sphingosides. He is a co-author of scientific articles, including those published in journals from Nature publishing group. He is also a co-author of numerous patents related to drug discovery.
The event is organized by the MUW Doctoral School within the framework of the STER Internationalization of Doctoral Schools program of the National Agency for Academic Exchange.